CRISPR-gene editing may enable treatment for hemoglobinopathies 

In a landmark study that could lead to new therapies for sickle cell anaemia and other blood disorders, Sydney-led researchers have used CRISPR-gene editing to introduce beneficial natural mutations into blood cells to boost their production of foetal haemoglobin. The research solves a 50-year-old mystery about how these mutations – which are naturally carried by ...

Already a member?

Login to keep reading.

© 2021 the limbic